Duke Endowment Grant to Fund Treatment Initiatives at GGC
March 13, 2014 - The Greenwood Genetic Center (GGC), which comprises the Department of Medical Genetics at Self Regional Healthcare, has been awarded a 3-year grant totalling $2.75 million from The Duke Endowment to fund an expansion of the Center's treatment initiatives.
Self Regional Healthcare Joins GGC and Clemson to Create National Hub for Genetics Research
GREENWOOD, S.C.(February 21, 2014) - A new partnership will establish formal collaboration among genetic researchers and Clemson University faculty at the Greenwood Genetic Center and Self Regional Healthcare, expanding an already successful working relationship.
January is Birth Defects Prevention Month in SC
Greenwood Genetic Center Teams Up with Community-Based Organization to Prevent Birth Defects
January 27, 2014 – "My job is to spread the word about how to have a healthy baby," shares Jane Dean, RN, who sits in her office at the Greenwood Genetic Center surrounded by the fruits of her work - countless photos of smiling babies which were shared with her by grateful parents. Dean is the Statewide Coordinator for the SC Birth Defects Prevention Program and works directly with families who have lost newborns or experienced the birth of a child with a severe birth defect of the brain and spine, known as a neural tube defect.
GGC Plays Crucial Role in FDA Clearance of CytoScan Dx
CytoScan® Dx Assay is the first whole genome test to gain diagnostic clearance
Greenwood, SC (January 22, 2014) – Two to three percent of children in the United States have some form of intellectual disability, many of which are associated with genetic changes. For these families, finding a diagnosis can be a journey that, if ever realized, may take months or even years.
Last week, the US Food and Drug Administration (FDA) granted the first-ever clearance for a whole-genome genetic test that with a single blood sample can scan a patient's entire genome searching for the cause of developmental and intellectual disabilities.
Affymetrix, Inc., based in Santa Clara, CA, partnering with Greenwood Genetic Center (GGC) and others, now has regulatory clearance to market CytoScan Dx Assay as a diagnostic test.
Office of Communications
Lori Bassett, MS, CGC
Fax (864) 388-1062